Abstract
Following exposure to calcium ionophore A23187, washed peripheral blood mononuclear cells (MNC) aggregated and formed thromboxane, like platelets. However, while aspirin strongly inhibited platelet aggregation and thromboxane formation, it had a little effect on the aggregation of MNC. In about 50% of the samples studied, aggregation of MNC was associated with the secretion of ATP. However studies in which exogenous ATP or ADP were used, suggested that the aggregation of MNC is independent of the secretion of nucleotides. MNC from 2 thrombasthenic patients failed to aggregate and bound 9–10 fold less radiolabelled fibrinogen than those from normals when challenged with A23187. However, fibrinogen, which plays a major role in the aggregation of platelets, did not appear to be involved in the aggregation of MNC. A differing behavior of these two types of cells was also found when the effect of plasma was studied on the aggregation response to A23187. Indeed, citrated plasma greatly enhanced the aggregation of platelets while it suppressed the response of MNC. This inhibitory effect of plasma was not detected when heparinized plasma was substituted for citrated plasma. We conclude that the aggregation of MNC in response to A23187 does not involve basic events known to play a major role in the aggregation of platelets. The response to A23187 may be an important probe for understanding basic mechanisms and pathophysiological significance of the aggregation of MNC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
B. M. Babior,Oxidants from phagocytes: agents of defense and destruction, Blood64, 959–966 (1984).
J. T. O'Flaherty, D. L. Kreutzer and P. A. Ward,Chemotactic factor influences on aggregation, swelling and foreign surface adhesiveness of human leukocytes, Am. J. Path.90, 537–550 (1978).
T. Yasaka, L. A. Boxer and R. L. Baenher,Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet activating factor, J. Immunol.128, 1939–1944 (1982).
S. Villa, F. Colotta, G. de Gaetano and N. Semeraro,Arachidonic acid and leukotriene B4 induce aggregation of human peripheral blood mononuclear leukocytes in vitro, Br. J. Haematol.58, 137–146 (1984).
S. P. Ackermas and S. D. Douglas,Morphology of monocytes and macrophages. InHaematology (Eds. W. J. Williams, E. Beutler, A. I. Erslev and M. A. Lichtman) pp. 837–847, MC Graw-Hill Book Company 1983.
N. A. Pawloski, G. Kaplan, A. L. Hamill, Z. A. Cohn and W. A. Scott,Arachidonic Acid metabolism by human monocytes. Studies with platelet depleted cultures, J. Exp. Med.158, 393–412 (1983).
D. C. Altieri, P. M. Mannucci and A. M. Capitanio,Binding of fibrinogen to human monocytes, J. Clin. Invest.78, 968–976 (1986).
R. B. Colvin and H. F. Dworak,Fibrinogen/fibrin on the surface of macrophages. Detection, distribution, binding requirements and possible role in macrophage adherence phenomena, J. Exp. Med.142, 1377–1390 (1975).
L. A. Sherman and J. Lee,Specific Binding of Soluble Fibrin to Macrophages, J. Exp. Med.145, 76–85 (1977).
N. Hogg,Human Monocytes are associated with the formation of fibrin, J. Exp. Med.157, 473–485 (1983).
S. J. Shattil and J. S. Bennett,Platelets and their membranes in hemostasis: physiology and pathophysiology, Ann. Int. Med.94, 108–118 (1981).
J. N. George, A. T. Nurden and D. R. Phillips,Molecular defects in the interactions of platelets with the vessel wall, N. Engl. J. Med.311, 1084–1088 (1984).
G. Di Minno, A. M. Cerbone, P. L. Mattioli, S. Turco, C. Iovine and M. Mancini,Functionally thrombasthenic state in normal platelets following the administration of ticlopidine, J. Clin. Invest.75, 328–338 (1985).
F. Colotta, G. Peri, A. Villa and A. Mantovani,Rapid Killing of actinomicyn D-treated tumor cells by human mononuclear cells I. Effector belong to the monocyte-macrophage lineage, J. Immunol.132, 936–944 (1984).
J. C. Doery, J. Hirsh and G. C. De Gruchy,Platelet glycolytic enzymes: effect of cellular disruption procedures on activity, Br. J. Haematol.19, 145–157 (1970).
I. F. Charo, R. D. Feinman and T. C. Detwiler,Interrelation of platelet aggregation and secretion, J. Clin. Invest.60, 866–872 (1977).
C. Malmsten, H. Kindhal, B. Samuelsson, S. Levy Toledano, G. Tolelem and J. P. Caen,Thromboxane synthesis and the platelet relase reaction in Bernard-Soulier syndrome, thrombasthenia Glanzmann and Hermansky-Pudlak syndrome, Br. J. Haematol.35, 511–520 (1977).
B. Perussia, J. Jankiewicz and G. Trinchieri,Binding of platelets to human monocytes: a source of artifacts in the study of specificity of antileukocyte antibodies, J. Immunol. Meth.50, 269–276 (1982).
A. T. Nurden and J. P. Caen,An abnormal glycoprotein pattern in three cases of Glanzmann's thrombasthenia, Br. J. Haematol.28, 253–260 (1974).
D. R. Phillips, C. S. P. Jenkins, E. F. Luscher and M. J. Larrieu,Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membrane, Nature (Lond)257, 599–600 (1975).
K. J. Klementson, J. L. Mc Gregor, R. P. Mc Ever, Y. V. Jaques, D. F. Baiton, W. Domzigand and M. Baggiolini,Absence of platelet membrane glycoprotein IIb/IIIa from monocytes, J. Exp. Med.161, 972–989 (1985).
J. J. Burckhardt, W. H. Kerr Anderson, J. F. Kearney and M. D. Cooper,Human blood monocytes and platelets share a cell surface component, Blood60, 767–771 (1982).
G. Gogstod, O. Hetland, N. O. Solum and H. Prydz,Monocytes and platelets share the glycoproteins IIb and IIIa that are absent from both cells in Glanzmann's thrombasthenia type J, Biochem. J.214, 331–337 (1983).
Y. Bai, H. Durbin and N. Hagg,Monoclonal antibodies specific for platelet glycoproteins react with human monocytes, Blood64, 139–146 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cerbone, A.M., Di Minno, G., Montemurro, P. et al. Aggregation of human peripheral blood mononuclear cells by calcium ionophore A23187. Comparison with the aggregation of platelets and defective response in Glanzmann's thrombasthenia. Agents and Actions 24, 165–171 (1988). https://doi.org/10.1007/BF01968096
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01968096